Katina Loucaides
General Counsel chez NUVO PHARMACEUTICALS INC.
Profil
Katina K.
Loucaides is currently working as the Secretary, Vice President & General Counsel at Nuvo Pharmaceuticals, Inc. since 2012.
She is also a Member at the Intellectual Property Institute of Canada.
Previously, she worked as the Secretary, Vice President & General Counsel at Crescita Therapeutics, Inc. from 2016 to 2017.
In terms of education, Ms. Loucaides completed her undergraduate and graduate degrees at the University of Toronto.
She also obtained a graduate degree from Osgoode Hall Law School.
Postes actifs de Katina Loucaides
| Sociétés | Poste | Début |
|---|---|---|
| NUVO PHARMACEUTICALS INC. | General Counsel | 01/01/2008 |
Intellectual Property Institute of Canada
 Intellectual Property Institute of Canada Intellectual Property Institute of Canada operates as a professional association of patent agents, trademark agents, and lawyers practicing in all areas of intellectual property (IP) law. The company was founded in 1926 and is headquartered in Ottawa, Canada. | Corporate Officer/Principal | - |
Anciens postes connus de Katina Loucaides
| Sociétés | Poste | Fin |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | General Counsel | 09/01/2017 |
Formation de Katina Loucaides
| University of Toronto | Graduate Degree |
| Osgoode Hall Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Intellectual Property Institute of Canada
Intellectual Property Institute of Canada Intellectual Property Institute of Canada operates as a professional association of patent agents, trademark agents, and lawyers practicing in all areas of intellectual property (IP) law. The company was founded in 1926 and is headquartered in Ottawa, Canada. |
